Wednesday, March 31, 2021
Home Business VTT report: Finnish pharmaceutical industry lags behind the rest of Europe -...
- Advertisement -

VTT report: Finnish pharmaceutical industry lags behind the rest of Europe – money and management as problems – Taloussanomat

Investments in the pharmaceutical industry in Finland have lagged behind other European countries in terms of the general development of the sector.

Technology VTT Research Center today published a report showing how research and production investments in the pharmaceutical industry could be increased in Finland and new high-skilled jobs created.

However, this will require pressure and a common goal from decision-makers, companies and funders.

The report shows that in recent years, investments in the pharmaceutical industry in Finland have lagged behind other European countries in terms of the general development of the sector.

As a remedy for this, the report presents three development paths, which are security of supply, from research to business, and the intelligent pharmaceutical industry.

- Advertisement -

Major however, the problem and challenge as a whole is funding. The current funding mechanisms in the sector and the needs of the pharmaceutical industry do not sufficiently meet.

In addition, one big challenge is taking responsibility and specifically its lack. According to the report, Finland seems to need a single responsible body that would bring together actors in the field.

There were no unambiguous answers as to who or what this leading body would have been.

Director of Santen Pharmaceutical and Rokote Laboratories Finland Pasi Kemppainen stated at the remote information conference that it is good in Finland to make plans, but bad to start work. Kemppainen takes responsibility from politicians.

- Advertisement -

– It’s just a state of mind. Look at Israel or Denmark. There are clear tones in terms of leadership and it is seen as a success for the pharmaceutical industry.

In the report it is proposed that the next focus should be on rapid response to the opportunities that the corona pandemic has contributed to.

Other proposals include the development of a national pharmaceutical strategy and a roadmap. This would bring together and schedule key actions to support the pharmaceutical industry until 2030.

In addition, the development of funding mechanisms to better meet industry needs and existing public and private funding is mentioned. The last point of proposal is national coordination for the implementation of the roadmap.



Source site www.is.fi

- Advertisement -
RELATED ARTICLES
- Advertisement -

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular

Recent Comments

- Advertisement -